Icosagen News



Join RSS feed »
In the News

October 03, 2008

« Back to news list

Quattromed Cell Factory signed a contract with Bayer HealthCare

Quattromed Cell Factory announced the signing of an agreement with Bayer HealthCare, pursuant to which Quattromed Cell Factory granted a licence to Bayer HealthCare to test novel QMCF technology with the option to proceed with a technology license

About Quattromed Cell Factory

Quattromed Cell Factory OÜ was established in 2005. The company is dedicated to the development of the portfolio of QMCF technology-based applications. The R&D work during 2005-2008 was performed in collaboration with Tartu University and financed by Enterprise Estonia.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. The pharmaceuticals research and business activities are focused on Diagnostic Imaging, General Medicine, Specialty Medicine and Women's Healthcare.

Find more information at www.bayerhealthcare.com and  www.bayerscheringpharma.de.

 

Additional information:

Marit Jaaska

Business Manager

Phone: +372 737 7070